03.14.24 -- Using Relational Risk Analysis To Control Procedure Failures In The Bio/Pharma & Medical Device Industry

Discover how an effective approach to risk management can further ensure the delivery of a high-quality drug or medicine to the patient.

Here, we focus on how the apparent melting approach can provide a rapid screening protocol for the detection and analysis of drug-excipient incompatibility in mixtures and formulas.

By founding their latest venture, Abpro, Ian and Eugene Chan are using their synergistic skillsets in business and medicine to rapidly generate antibodies that treat cancer and autoimmune diseases.

Explore the role of solid form services in helping to meet the accelerated timelines of the drug development lifecycle along with examples of robust workflows for fast and thorough solid form screens.

Examine a maturity model that was created to help you better understand where you are on your DataOps journey and where you need to go to achieve the results you expect.

Learn how to obtain highly-sensitive, quantitative measurements in real-time without specific tracer gases.

The challenges of silicone-oil lubrication and the growing trend for more viscous, protein-based drugs are now leading pharma and biotech companies to investigate alternative solutions.

Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based on which countries are involved and the types of services required.

Learn how a CDMO that is experienced in producing and characterizing diverse recombinant proteins is essential when accelerating the successful transfer of recombinant protein analytical assays.

Federal Equipment's Matt Hicks was interviewed by Don Davison on the Life Science Success podcast. Hear them discuss Matt’s career and how Federal Equipment buys and sells pharmaceutical equipment.

Review the case study and learn how KinetiSol Solid Dispersion lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.

Here, we examine the cause and impact of common errors in quality control (QC) labs, the strategy for reducing those errors with an intuitive chromatography system, and more.

Drs. Joachim Klein and Rebecca Michael from Lonza Pharma & Biotech answer attendee questions from a recent webinar about Lonza’s options for expressing and manufacturing complex biologic drugs.